Recruiting Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma. NCT07686835 Conditions Melanoma, Melanoma (Skin Cancer), Melanoma (Skin) Stage IV, +13 more Locations Medical Oncology — Nijmegen, Gelderland, Netherlands Universitair Medisch Centrum Groningen — Groningen, Provincie Groningen, Netherlands View Trial Details
Recruiting RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma NCT07445022 Conditions Melanoma Advanced Locations Fudan University Shanghai Cancer Center — Shanghai, China View Trial Details
Recruiting Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy. NCT06784778 Conditions Melanoma, Melanoma Advanced, Melanoma Metastatic, +13 more Locations Universitätsklinikum Tübingen — Tübingen, Baden-Wurttemberg, Germany Heidelberg University Hospital — Heidelberg, Germany LMU Klinikum — München, Germany View Trial Details
Active, Not Recruiting A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma NCT05732805 Conditions Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +16 more Locations Healthcare Institution "Bobruisk Interdistrict Oncological Dispensary" — Babruysk, Belarus Healthcare Institution "Brest Regional Oncological Dispensary" — Brest, Belarus Health care institution "Grodno University Clinic" — Grodno, Belarus Health Institution "Gomel Regional Clinical Oncology Center" — Homyel, Belarus View all 63 locations View more locations Show fewer locations Loading locations... View Trial Details
